focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIIT.L Regulatory News (IIT)

  • There is currently no data for IIT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

18 Jan 2018 07:00

RNS Number : 1821C
Independent Investment Trust PLC
18 January 2018
 

RNS Announcement: Preliminary Results

 

The Independent Investment Trust PLC

 

The following is the unaudited preliminary statement for the year to 30 November 2017 which was approved by the board on 17 January 2018.

 

Chairman's Statement

 

Over the year to 30 November 2017, our company produced a net asset value (NAV) total return of 54.8%. However one measures performance this was, by some margin, the best annual result in the history of the Independent: theoretical investments in the FTSE All-Share Index and the FTSE World Index would have produced total returns of 13.4% and 15.4% respectively. For the period from inception in October 2000 to 30 November 2017, we produced an NAV total return of 788%, equivalent to a rate of roughly 13.7% per annum, of which 2.8% per annum can be offset by RPI inflation. By comparison, the notional return available from the FTSE All-Share Index over the period amounted to 146%, or 5.4% per annum. Our performance is to the great credit of Max Ward, who has managed the portfolio from inception.

The results rekindled enthusiasm for our shares, which moved from a discount of 11.2% at 30 November 2016 to a premium of 7.2% at 30 November 2017, producing a share price total return of 87.0%.

Two factors were particularly helpful to us in the year under review. First, it was a market environment in which investors were happy to re-rate companies with a good story and results to match. This was particularly true of UK domestic companies, such as the housebuilders, whose valuations were artificially depressed in the wake of the vote to leave the European Union. Secondly, an unusually high proportion of our companies produced operating results during the period that exceeded expectations. Either or both of these factors could reverse at any time.

Once again, there has been little change in the global economic background. Growth has been unexciting; inflation has been generally modest; and consumer spirits have been subdued by limited real wage gains (indeed, real wages have declined in the UK). Interest rates have started to rise in some parts of the world, but at a slower pace than some would have liked. The overwhelming impression is of policymakers trying to direct events that have a mind of their own. Markets have once again benefited from a combination of loose monetary policy and high levels of corporate profitability.

The main changes in our sectoral distribution have been a reduction in the importance of our housebuilding stake as we sold out of Berkeley Group and a significant increase in our exposure to the technology and telecommunications sector (despite modest net sales). The emergence of the latter as our largest sector marks a major change in our thinking in recent years. Up until 2014 we did not trust ourselves to invest in individual small technology companies, fearing that we lacked the relevant specialist expertise. Instead, we delegated the task, very successfully, to Katie Potts and her team at Herald Investment Trust. Since 2014 we have been able to persuade ourselves in the case of a growing number of small technology companies that we understand enough about their businesses to justify investing directly. Our results to date have exceeded our wildest hopes, but have not blinded us to the risks of investing in highly rated companies operating in fast changing markets. Our greater willingness to invest directly in this area has led to a less obvious role for Herald in our portfolio and we have reduced the holding accordingly.

We ended our year with cash balances of just over 7% of shareholders' funds (5% at 30 November 2016). Further comments on the portfolio can be found in the Managing Director's Report below.

Earnings per share for the year were 9.2p (7.93p in 2016). Given the buoyancy of our revenue account and an encouraging outlook, we have decided to recommend a final dividend of 4p (nil in 2016), making a total regular dividend of 6p (5p in 2016). In addition, we are proposing a special dividend of 2p (2.5p in 2016). If approved, both will be paid on 6 April with an ex-dividend date of 22 February.

 

The growth in our assets had a beneficial effect on our ongoing charges ratio, which fell from 0.34% to 0.25%. Not only is this one of the lowest ratios in the industry - if not the lowest - but the level of 0.25% is also a record low for us.

In the early part of our year, our shares traded at a discount to NAV and we were able to buy back 60,000 at a discount of 7.3%. In normal market conditions we are happy to buy back shares when this can be done on terms that are not detrimental to the interests of continuing shareholders.

It is now nine years since the FTSE All Share Index last delivered a negative total return over a year ending on 30 November. Over that nine year period total returns for the index have averaged comfortably over 10% per annum, which is far in excess of UK - or global - economic growth for the period. Common sense would suggest that we are overdue a significant market correction, but in the absence of any clear indication of the timing of such a correction we see little point in trying to anticipate it. Our companies are in good fettle and we are confident about their long term prospects. This is the foundation on which our future strategy is based.

Once again, we should like to encourage you to come to the AGM, which is to be held in the Baillie Gifford offices at Calton Square at 4.30pm on 22 March 2018. It will help our planning if we know how many shareholders are likely to attend, and I shall be grateful if you will mark the proxy form accordingly and return it to the Company's registrars. I look forward to seeing as many of you as possible there.

 

 

Douglas McDougall

17 January 2018

 

Past performance is not a guide to future performance.

For a definition of terms see Glossary of Terms.

Total return information is sourced from Baillie Gifford /Thomson Reuters DataStream. See disclaimer at the end of this announcement.

 

 

 

Managing Director's Report

 

Our performance over the year has been covered in the Chairman's Statement.

It has been a remarkable year for our large technology and telecommunications stake: worth £44.6m at 30 November 2016, it had risen in value to £87.4m by 30 November 2017 after net sales of £1.1m. Strong share price performances led us to make reductions in our holdings of FDM, Gamma Communications and Kainos. In each case this was a mistake as all three companies produced strong results. We also made a reduction in our holding in Herald Investment Trust to address the issue of overlap between our two portfolios. This, too, was a mistake as the Herald discount fell after we sold in recognition of strong investment results. Fortunately, we were less trigger happy in the case of our Blue Prism holding, which went from strength to strength throughout the year as demand for its software robots grew at quite extraordinary rates. We do not pretend to know what the "right" valuation for the company is, but we continue to believe that it could grow to many times its current size in a relatively short space of time if it maintains its position of leadership in the embryonic market for robotic process automation. Our two new technology holdings, Alfa Financial Software and Frontier Developments, both made encouraging debuts. Alfa, one of the leading providers of software to the asset finance industry, is renowned for the quality of its products and for its ability to deliver complex implementations on time and on budget. Frontier is a long established designer of computer games which is benefiting from the transformational effect of the cloud on the design and marketing of computer games. It is also notable for having attracted the attention of the giant Chinese internet company, Tencent, which has taken a 9% stake in it.

It has been a much better year for our large position in the housebuilding industry. Conditions in the housing market have been about as favourable as they could be for builders. A plentiful supply of land at very attractive prices combined with robust demand, albeit helped at the lower end of the market by the government's Help to Buy scheme, to provide strong sales at good margins. The one exception to this happy picture is the retirement homes builder, McCarthy and Stone, which has again been held back by a sluggish market for second hand houses. There are now, however, clear signs of improvement even in its business. Strong profits and dividends have been rewarded with good share price performances, but in the case of most of our holdings we think the market continues to undervalue their long-term prospects. Berkeley Group, which we held until October, is the one exception to this: its dependence on the London market and its policy of selling well ahead have left it with very high profits in the current year, but a more subdued outlook thereafter. Despite the undoubted quality of the business, we decided to sell our holding at a very good profit. Overall, despite sales of £7.7m, the value of our housebuilding stake rose from £51.0m at 30 November 2016 to £59.4m at 30 November 2017.

It has been another good year for our travel and leisure holdings: their value grew from £24.7m at 30 November 2016 to £34.8m at 30 November 2017 despite net sales of £1.8m. The main contributor to this performance, as was the case in 2016, was the online package holiday company, On the Beach, which has once again delivered strong earnings growth against a difficult market background. The strength of its customer proposition - low prices and flexible booking arrangements - is becoming increasingly apparent. Gym Group delivered another year of good growth and was rewarded with a strong recovery in its share price. The performance of the Hollywood Bowl share price was more subdued, but there was nothing wrong with its operating results.

Given our disappointing record as investors in the retail sector, it may seem perverse that we have significantly increased our exposure to it at a time when there are widespread concerns about the outlook for consumer spending. It is our hope that our new purchases, Footasylum and Quiz, will turn out to be resilient in a tough consumer environment and we believe that our addition to our old favourite, Dunelm, was made at an attractive valuation even given the uncertainties surrounding its immediate outlook. Both Footasylum and Quiz are clothing retailers. They serve totally different markets, but share the common characteristic (also shared with Joules, which we bought in 2016) of having developed a successful multichannel approach, in which the website and the physical estate feed off each other's strengths. The net result is rapid growth in internet sales combined with very fast paybacks on new store openings. All three are highly cash generative businesses. Motorpoint, our other retail holding, has seen a strong rebound in its share price as results have recovered from the disappointing spell of trading in the wake of the referendum. Overall, the value of our retail holdings rose from £15.2m at 30 November 2016 to £31.7m at 30 November 2017 after net purchases of £11.0m.

Once again we consider it appropriate to devote an entire paragraph to the soft drinks company, Fever-Tree. Fever-Tree's international business (probably 40% of total sales) is growing at over 40% per annum and in each of its geographical areas it dominates the premium segment of the mixer market. We think premium mixers will continue to gain market share for years to come because they are starting from a low base and we expect Fever-Tree to be at the forefront of this trend. Rather reluctantly, we took some profits towards the end of the year on grounds of valuation, but despite this it retained its position as our largest holding.

It has been a year of considerable change for our holdings in the business services sector: we sold out of SThree and Gama Aviation, added to Midwich and bought a new holding in Eddie Stobart Logistics. SThree has struggled in recent years to reprise the growth rates it achieved when we originally bought it, while Gama was sold largely on grounds of illiquidity. Our addition to Midwich was well timed and it is pleasing to see the attributes that attracted us to this exceptionally well-run business are now beginning to achieve wider recognition. Eddie Stobart, however, has failed to attract a following in the wake of its initial public offering despite reporting good results. Overall, our business services stake grew in value from £11.4m to £25.9m after net purchases of £3.8m.

Elsewhere in the portfolio, good results were reflected in the share prices of Ashtead and Luceco (although the latter issued a profits warning after our year end). Our new holding in RPC, the oil service company, enjoyed a good share price performance. The same was true of teleradiology company, Medica, but in its case much of the share price strength has reversed since our year end in the wake of a disappointing trading statement. The Polar Capital Global Insurance Fund had a quiet year, while NAHL, to which we started to add towards the end of our year, saw its share price affected by uncertainty (which we consider largely resolved now) about the future of personal injury litigation. We sold Telecom Plus and Bluefield Solar on grounds of valuation, and disposed of The AA and UP Global in the wake of disappointing trading news.

 

Max Ward

17 January 2018

 

 

List of Investments as at 30 November 2017 (unaudited)

 

Sector

Name

Value

2016

£'000

 

Net transactions

£'000

 

Gains/ (losses)

£'000

 

Value

2017

£'000

 

%

Housing

Bellway

4,882

 

 

2,036 

 

6,918

 

2.0

 

Berkeley Group

4,952

 

(7,733)

 

2,781 

 

-

 

-

 

Crest Nicholson

13,113

 

 

1,992 

 

15,105

 

4.5

 

McCarthy and Stone

8,315

 

 

(95)

 

8,220

 

2.4

 

Persimmon

3,398

 

 

1,676 

 

5,074

 

1.5

 

Redrow

16,344

 

 

7,696 

 

24,040

 

7.1

 

 

51,004

 

(7,733)

 

16,086 

 

59,357

 

17.5

Industrials

Ashtead Group

15,640

 

 

3,350 

 

18,990

 

5.6

Retailing

Dunelm Group

5,908

 

4,182 

 

432 

 

10,522

 

3.1

 

Footasylum

-

 

3,409 

 

691 

 

4,100

 

1.2

 

Joules Group

3,660

 

(1,327)

 

1,717 

 

4,050

 

1.2

 

Motorpoint

5,670

 

 

2,655 

 

8,325

 

2.5

 

Quiz

-

 

4,782 

 

(42)

 

4,740

 

1.4

 

 

15,238

 

11,046 

 

5,453 

 

31,737

 

9.4

Consumer Services

AA

5,308

 

(5,194)

 

(114)

 

-

 

-

 

NAHL Group

3,056

 

183 

 

(625)

 

2,614

 

0.8

 

 

8,364

 

(5,011)

 

(739)

 

2,614

 

0.8

Consumer Goods

Luceco

5,744

 

(1,469)

 

2,976 

 

7,251

 

2.1

 

Up Global Sourcing

-

 

664 

 

(664)

 

-

 

-

 

 

5,744

 

(805)

 

2,312 

 

7,251

 

2.1

Travel and Leisure

Hollywood Bowl Group

6,680

 

 

440 

 

7,120

 

2.1

 

On the Beach Group

13,260

 

(1,814)

 

9,818 

 

21,264

 

6.3

 

The Gym Group

4,770

 

 

1,680 

 

6,450

 

1.9

 

 

24,710

 

(1,814)

 

11,938 

 

34,834

 

10.3

Business Services

Eddie Stobart Logistics

-

 

11,176 

 

(256)

 

10,920

 

3.2

 

Gama Aviation

2,360

 

(4,591)

 

2,231 

 

-

 

-

 

Midwich

4,945

 

2,069 

 

7,986 

 

15,000

 

4.5

 

SThree

4,125

 

(4,851)

 

726 

 

-

 

-

 

 

11,430

 

3,803 

 

10,687 

 

25,920

 

7.7

Technology and

Alfa Financial Software

-

 

9,372 

 

2,751 

 

12,123

 

3.6

Telecommunications

Blue Prism

5,780

 

(838)

 

22,320 

 

27,262

 

8.1

 

FDM Group

13,125

 

(7,198)

 

8,286 

 

14,213

 

4.2

 

Frontier Developments

-

 

5,977 

 

2,473 

 

8,450

 

2.5

 

Gamma Communications

4,735

 

(2,645)

 

925 

 

3,015

 

0.9

 

Herald Investment Trust

16,500

 

(4,638)

 

5,778 

 

17,640

 

5.2

 

Kainos Group

4,455

 

(1,148)

 

1,418 

 

4,725

 

1.4

 

 

44,595

 

(1,118)

 

43,951 

 

87,428

 

25.9

Beverages

Fever-Tree Drinks

19,242

 

(8,157)

 

18,075 

 

29,160

 

8.6

Utilities

Telecom Plus

5,000

 

(4,813)

 

(187)

 

-

 

-

Healthcare

Medica Group

-

 

5,779 

 

2,701 

 

8,480

 

2.5

Insurance

Polar Capital Global Insurance Fund -

Ireland

4,408

 

 

381 

 

4,789

 

1.4

Energy/Oilfield Services

RPC - USA

-

 

2,823 

 

729 

 

3,552

 

1.0

Renewable Energy Funds

Bluefield Solar Income - Channel Islands

5,187

 

(5,691)

 

504 

 

-

 

-

Total Investments

 

210,562

 

(11,691)

 

115,241 

 

314,112

 

92.8

Net Liquid Assets

 

10,308

 

14,063 

 

(32)

 

24,339

 

7.2

Shareholders' Funds

 

220,870

 

2,372 

 

115,209 

 

338,451

 

100.0

 

The above table excludes holdings valued at nil. All holdings are in equities domiciled in the UK unless otherwise stated.

 

 

 

 

 

 

 

Income statement

 

 

For the year ended

30 November 2017 (unaudited)

For the year ended

30 November 2016 (audited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Gains on investments

115,241 

115,241 

5,720

5,720 

Currency (losses)/gains

(32)

(32)

139

139 

Income (note 2)

5,830 

5,830 

5,139 

-

5,139 

Administrative expenses

(721)

(721)

(719)

-

(719)

Net return on ordinary activities before taxation

5,109 

115,209 

120,318 

4,420 

5,859

10,279 

Tax on ordinary activities

(3)

(3)

-

Net return on ordinary activities after taxation

5,106 

115,209 

120,315 

4,420 

5,859

10,279 

Net return per ordinary share: basic (note 3)

9.20p

207.67p

216.87p

7.93p

10.51p

18.44p

Note:

Dividends per share paid and payable in respect of the year (note 4)

8.00p

 

 

 

 

7.50p

 

 

 

 

The total column of this statement is the profit and loss account of the Company. The supplementary revenue and capital columns are prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in this statement derive from continuing operations.

A Statement of Comprehensive Income is not required as all gains and losses of the Company have been reflected in the above statement.

 

 

Balance sheet

 

 

At 30 November 2017 (unaudited)

At 30 November 2016 (audited)

 

£'000

£'000

£'000

£'000

Fixed assets

 

 

 

 

Investments held at fair value through profit or loss

 

314,112

 

210,562

Current assets

 

 

 

 

Debtors

798 

 

115 

 

Cash and cash equivalents

23,704 

 

10,247 

 

 

24,502 

 

10,362 

 

Creditors

 

 

 

 

Amounts falling due within one year

(163)

 

(54)

 

Net current assets

 

24,339

 

10,308

Total net assets

 

338,451

 

220,870

 

 

 

 

 

Capital and reserves

 

 

 

 

Share capital

 

13,867

 

13,882

Share premium account

 

15,242

 

15,242

Special distributable reserve

 

16,387

 

16,625

Capital redemption reserve

 

2,665

 

2,650

Capital reserve

 

283,191

 

167,982

Revenue reserve

 

7,099

 

4,489

Shareholders' funds

 

338,451

 

220,870

Net asset value per ordinary share (note 5)

 

610.2p

 

397.7p

 

 

 

Statement of changes in equity

 

For the year ended 30 November 2017 (unaudited)

 

Share capital

£'000

Share premium account

£'000

Special distributable reserve

£'000

Capital redemption reserve

£'000

Capital

reserve*

£'000

Revenue reserve

£'000

 

Shareholders'funds

£'000

Shareholders' funds at 1 December 2016

13,882 

15,242

16,625 

2,650

167,982

4,489 

220,870 

Net return on ordinary activities after taxation

-

-

115,209

5,106 

120,315 

Shares bought back for cancellation (note 5)

(15)

-

(238)

15

-

(238)

Dividends paid during the year

(note 4)

-

-

-

(2,496)

(2,496)

Shareholders' funds at 30 November 2017

13,867 

15,242

16,387 

2,665

283,191

7,099 

338,451 

 

 

For the year ended 30 November 2016 (audited)

 

 Share capital

£'000

Share premium account

£'000

Special distributable reserve

£'000

Capital redemption reserve

£'000

Capital

reserve*

£'000

Revenue reserve

£'000

 

Shareholders'funds

£'000

Shareholders' funds at 1 December 2015

14,032 

15,242

18,831 

2,500

162,123

6,243 

218,971 

Net return on ordinary activities after taxation

-

-

5,859

4,420 

10,279 

Shares bought back for cancellation (note 5)

(150)

-

(2,206)

150

-

(2,206)

Dividends paid during the year

(note 4)

-

-

-

(6,174)

(6,174)

Shareholders' funds at 30 November 2016

13,882 

15,242

16,625 

2,650

167,982

4,489 

220,870 

 

* The Capital Reserve balance at 30 November 2017 included an investment holding gain on fixed asset investments of £145,636,000 (2016 - gain of £57,240,000).

 

 

Notes (unaudited)

1.

The unaudited financial statements for the year to 30 November 2017 have been prepared in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. The accounting policies adopted are consistent with those of the previous financial year. The Company has elected not to present a Statement of Cash Flows for the current year as a Statement of Changes in Equity has been provided and substantially all of the Company's investments are highly liquid and are carried at market value.

2.

Income

Year to

30 November 2017

£'000

Year to

30 November 2016

£'000

Income from investments and interest receivable

5,808

5,120

Other income

22

19

 

5,830

5,139

 

 

 

 

3.

Net return per ordinary share

Year to 30 November 2017

Year to 30 November 2016

 

Revenue

Capital

Total

Revenue

Capital

Total

Net return on ordinary activities after taxation (£'000)

5,106

115,209

120,315

4,420

5,859

10,279

Weighted average number of ordinary shares in issue during the year

55,477,890

55,738,196

Net return per ordinary share: Basic

9.20p

207.67p

216.87p

7.93p

10.51p

18.44p

 

Returns per ordinary share are based on the return for the financial year and on the weighted average number of ordinary shares in issue during the year as shown above. There are no dilutive or potentially dilutive shares in issue.

4.

Ordinary dividends

Year to

30 November 2017

Year to

30 November 2016

 

Pence

£'000

Pence

£'000

Amounts recognized as distributions in the year:

 

 

 

 

Previous year's second interim dividend

-

-

3.00

1,684

Previous year's special dividend paid 6 April 2017

2.50

1,387

3.00

1,684

Interim dividend paid 25 August 2017

2.00

1,109

5.00

2,806

 

 

4.50

2,496

11.00

6,174

 

Set out below are the total dividends paid and proposed in respect of the financial year, which is the basis on which the requirements of section 1158 of the Corporation Tax Act 2010 are considered. The revenue available for distribution by way of dividend for the year is £5,106,000 (2016 - £4,420,000).

 

Ordinary dividends

Year to

30 November 2017

Year to

30 November 2016

 

Pence

£'000

Pence

£'000

 

Amounts paid and payable in respect of the year:

 

 

 

 

 

Interim dividend paid 25 August 2017

2.00

1,109

5.00

2,806

 

Final dividend payable 6 April 2018

4.00

2,219

-

-

 

Special dividend payable 6 April 2018

2.00

1,109

2.50

1,388

 

 

8.00

4,437

7.50

4,194

 

If approved, the recommended final and special dividends will be paid on 6 April 2018 to all shareholders on the register at the close of business on 23 February 2018. The ex-dividend date is 22 February 2018.

           

 

 

 

 

 

5.

Net asset value per ordinary share

At 30 November

2017

£000

At 30 November

2016

£'000

 

Net asset value attributable to ordinary shares

338,451

220,870

 

Net asset value per share is based on net assets (as shown above) and on 55,470,000 shares (2016 - 55,530,000), being the number of shares in issue at the year end. There are no dilutive or potentially dilutive shares in issue.

During the year the Company bought back and cancelled 60,000 (2016 - 600,000) ordinary shares with a nominal value of £15,000 (2016 - £150,000) at a cost of £238,000 (2016 - £2,206,000). No shares were allotted during the year. At 30 November 2017 the Company had authority remaining to buy back a further 8,314,953 ordinary shares and to allot new shares up to an aggregate nominal value amount of £4,774,939.

6.

Transaction costs incurred on the purchase and sale of the investments are added to the purchase cost or deducted from the sale proceeds, as appropriate. During the year, transaction costs on purchases amounted to £153,000 (2016 - £64,000) and transaction costs on sales amounted to £155,000 (2016 - £99,000).

7.

The financial information set out above does not constitute the Company's statutory accounts for the year ended 30 November 2017. The financial information for 2016 is derived from the financial statements for 2016 which have been delivered to the Registrar of Companies. The auditors have reported on the 2016 accounts; their report was unqualified, did not include a reference to any matters to which the auditors drew attention by way of emphasis without qualifying the report and did not contain a statement under sections 498 (2) or 498(3) of the Companies Act 2006. The statutory accounts for 2017 will be finalised on the basis of the financial information presented in this preliminary announcement and will be delivered to the Registrar of Companies following the Company's Annual General Meeting. The Auditors have advised the Company that they do not expect their report on the 2017 statutory accounts to include any modification or emphasis of matter statements.

8.

The Report and Accounts will be available on the Company's website www.independentinvestmenttrust.co.uk on or around 12 February 2018.

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

None of the views expressed in this document should be construed as advice to buy or sell a particular investment.

 

Glossary of Terms

 

Total Assets

The total value of all assets held less all liabilities (other than liabilities in the form of borrowings).

Net Asset Value

Net Asset Value (NAV) is the value of total assets held less all liabilities (including liabilities in the form of borrowings). The NAV per share is calculated by dividing this amount by the number of ordinary shares in issue.

Discount/Premium

As stock markets and share prices vary, an investment trust's share price is rarely the same as its NAV. When the share price is lower than the NAV per share it is said to be trading at a discount. The size of the discount is calculated by subtracting the share price from the NAV per share and is usually expressed as a percentage of the NAV per share. If the share price is higher than the NAV per share, this situation is called a premium.

Net Liquid Assets

Net liquid assets comprise current assets less current liabilities, excluding borrowings.

Total Return

The total return is the return to shareholders after reinvesting the net dividend on the date that the share price goes ex-dividend.

Ongoing Charges

The total administrative expenses incurred by the Company as a percentage of the average shareholders' funds.

Gearing

At its simplest, gearing is borrowing. Just like any other public company, an investment trust can borrow money to invest in additional investments for its portfolio. The effect of the borrowing on the shareholders' assets is called 'gearing'. If the Company's assets grow, the shareholders' assets grow proportionately more because the debt remains the same. But if the value of the Company's assets falls, the situation is reversed. Gearing can therefore enhance performance in rising markets but can adversely impact performance in falling markets.

 

Third Party Data Provider Disclaimer

No third party data provider ('Provider') makes any warranty, express or implied, as to the accuracy, completeness or timeliness of the data contained herewith nor as to the results to be obtained by recipients of the data. No Provider shall in any way be liable to any recipient of the data for any inaccuracies, errors or omissions in the index data included in this document, regardless of cause, or for any damages (whether direct or indirect) resulting therefrom. No Provider has any obligation to update, modify or amend the data or to otherwise notify a recipient thereof in the event that any matter stated herein changes or subsequently becomes inaccurate. Without limiting the foregoing, no Provider shall have any liability whatsoever to you, whether in contract (including under an indemnity), in tort (including negligence), under a warranty, under statute or otherwise, in respect of any loss or damage suffered by you as a result of or in connection with any opinions, recommendations, forecasts, judgments, or any other conclusions, or any course of action determined, by you or any third party, whether or not based on the content, information or materials contained herein.

 

FTSE Index data

FTSE International Limited ('FTSE') © FTSE 2017. 'FTSE®' is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under licence. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data and no party may rely on any FTSE indices, ratings and/or data underlying data contained in this communication. No further distribution of FTSE Data is permitted without FTSE's express written consent. FTSE does not promote, sponsor or endorse the content of this communication.

 

Legal Entity Identifier: 213800IYHGJTZJ3MO642

Regulated Information Classification: Additional regulated information required to be disclosed under the laws of a Member State of the European Union

- ends -

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR FKODPPBKDFDD
Date   Source Headline
3rd Nov 202210:45 amRNSNet Asset Value(s)
2nd Nov 202210:41 amRNSNet Asset Value(s)
1st Nov 202212:33 pmRNSNet Asset Value(s)
31st Oct 20222:02 pmRNSResult of Meeting
31st Oct 202210:48 amRNSNet Asset Value(s)
28th Oct 202210:59 amRNSNet Asset Value(s)
27th Oct 202210:35 amRNSNet Asset Value(s)
26th Oct 202210:57 amRNSNet Asset Value(s)
25th Oct 202212:01 pmRNSNet Asset Value(s)
24th Oct 20225:30 pmRNSIndependent Investment Trust PLC
24th Oct 202210:21 amRNSNet Asset Value(s)
21st Oct 202211:17 amRNSNet Asset Value(s)
20th Oct 202211:06 amRNSNet Asset Value(s)
19th Oct 202210:05 amRNSNet Asset Value(s)
18th Oct 202211:17 amRNSNet Asset Value(s)
17th Oct 202211:21 amRNSNet Asset Value(s)
17th Oct 202211:21 amRNSNet Asset Value(s)
14th Oct 202212:32 pmRNSNet Asset Value(s)
13th Oct 202210:32 amRNSNet Asset Value(s)
12th Oct 202210:18 amRNSNet Asset Value(s)
11th Oct 202210:48 amRNSNet Asset Value(s)
10th Oct 202211:03 amRNSNet Asset Value(s)
7th Oct 202210:12 amRNSNet Asset Value(s)
6th Oct 202211:39 amRNSPre-liquidation interim dividend
6th Oct 202211:33 amRNSPublication of a Circular
6th Oct 202210:15 amRNSNet Asset Value(s)
5th Oct 202210:43 amRNSNet Asset Value(s)
4th Oct 202210:21 amRNSNet Asset Value(s)
3rd Oct 202211:48 amRNSNet Asset Value(s)
30th Sep 202212:33 pmRNSNet Asset Value(s)
29th Sep 202211:00 amRNSNet Asset Value(s)
28th Sep 202212:18 pmRNSNet Asset Value(s)
27th Sep 202210:44 amRNSNet Asset Value(s)
26th Sep 202211:39 amRNSNet Asset Value(s)
23rd Sep 202211:18 amRNSNet Asset Value(s)
22nd Sep 202210:52 amRNSNet Asset Value(s)
21st Sep 202211:53 amRNSNet Asset Value(s)
20th Sep 202212:37 pmRNSNet Asset Value(s)
20th Sep 202210:42 amRNSNet Asset Value(s)
16th Sep 202211:09 amRNSNet Asset Value(s)
15th Sep 202211:19 amRNSNet Asset Value(s)
14th Sep 202210:31 amRNSNet Asset Value(s)
13th Sep 202211:26 amRNSNet Asset Value(s)
12th Sep 202210:47 amRNSNet Asset Value(s)
9th Sep 202211:24 amRNSNet Asset Value(s)
8th Sep 202210:04 amRNSNet Asset Value(s)
7th Sep 202211:10 amRNSNet Asset Value(s)
6th Sep 202211:19 amRNSNet Asset Value(s)
5th Sep 202210:52 amRNSNet Asset Value(s)
2nd Sep 202212:43 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.